semaglutide and beta blockers Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, Emerging Strategies Weight loss drug semaglutide reduces

Users wondering why they are not losing weight on semaglutide should also consider that persistent diarrhea can impair nutrient absorption and metabolic efficiency

Read more: To view or add a comment, sign in Great overview of the ALPS trial examining anti-arrhythmic therapy in out-of-hospital cardiac arrest

One advantage of GLP-1s is their ability to promote weight loss

Phase II enzymes, such as GSTs, conjugate these metabolites with endogenous molecules like GSH, neutralizing toxicity

glycolysis, oxidative phosphorylation, anaplerosis and transamination, linking it to neurotransmitter metabolism, energy production and redox homeostasis